Skip to main content

Paradigm Losses Down, Revenues Up for Q1 of FY2004

NEW YORK, April 27 (GenomeWeb News) - Paradigm Genetics today reported an improved net loss and increased revenues for the first quarter of fiscal year 2004.

 

The company said it had a net loss of $3.7 million, as compared to $4.1 million for the same quarter last year. Total revenues increased to $4.9 million from $4.1 million during the same quarter last year.

 

As of March 31, Paradigm had $15.2 million in unrestricted cash, cash equivalents, and short-term investments.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.